CA3062763A1 - Diagnostic biomarkers for detecting, subtyping, and/or assessing progression of multiple sclerosis - Google Patents
Diagnostic biomarkers for detecting, subtyping, and/or assessing progression of multiple sclerosis Download PDFInfo
- Publication number
- CA3062763A1 CA3062763A1 CA3062763A CA3062763A CA3062763A1 CA 3062763 A1 CA3062763 A1 CA 3062763A1 CA 3062763 A CA3062763 A CA 3062763A CA 3062763 A CA3062763 A CA 3062763A CA 3062763 A1 CA3062763 A1 CA 3062763A1
- Authority
- CA
- Canada
- Prior art keywords
- group
- autoantigen
- autoantibody
- subject
- specific
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000006417 multiple sclerosis Diseases 0.000 title claims abstract description 187
- 239000000104 diagnostic biomarker Substances 0.000 title claims description 18
- 239000000090 biomarker Substances 0.000 claims abstract description 147
- 238000000034 method Methods 0.000 claims abstract description 144
- 208000007400 Relapsing-Remitting Multiple Sclerosis Diseases 0.000 claims abstract description 97
- 238000003745 diagnosis Methods 0.000 claims abstract description 20
- 230000000750 progressive effect Effects 0.000 claims abstract description 10
- 239000000523 sample Substances 0.000 claims description 99
- 239000012472 biological sample Substances 0.000 claims description 57
- 239000011541 reaction mixture Substances 0.000 claims description 55
- 239000000758 substrate Substances 0.000 claims description 52
- 238000001514 detection method Methods 0.000 claims description 46
- 230000015572 biosynthetic process Effects 0.000 claims description 45
- 238000002493 microarray Methods 0.000 claims description 36
- 238000003018 immunoassay Methods 0.000 claims description 32
- 241000282414 Homo sapiens Species 0.000 claims description 28
- 230000027455 binding Effects 0.000 claims description 28
- 239000007787 solid Substances 0.000 claims description 28
- 108060003951 Immunoglobulin Proteins 0.000 claims description 27
- 102000018358 immunoglobulin Human genes 0.000 claims description 27
- 210000004369 blood Anatomy 0.000 claims description 25
- 239000008280 blood Substances 0.000 claims description 25
- 238000003556 assay Methods 0.000 claims description 21
- 239000011521 glass Substances 0.000 claims description 19
- 239000003814 drug Substances 0.000 claims description 17
- 210000002966 serum Anatomy 0.000 claims description 16
- 239000003153 chemical reaction reagent Substances 0.000 claims description 15
- 230000001225 therapeutic effect Effects 0.000 claims description 15
- 229940124597 therapeutic agent Drugs 0.000 claims description 12
- 239000000020 Nitrocellulose Substances 0.000 claims description 11
- 229920001220 nitrocellulos Polymers 0.000 claims description 11
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims description 10
- 238000002372 labelling Methods 0.000 claims description 9
- 206010036790 Productive cough Diseases 0.000 claims description 8
- 210000003296 saliva Anatomy 0.000 claims description 8
- 210000003802 sputum Anatomy 0.000 claims description 8
- 208000024794 sputum Diseases 0.000 claims description 8
- 238000003119 immunoblot Methods 0.000 claims description 6
- 238000001114 immunoprecipitation Methods 0.000 claims description 6
- 210000002381 plasma Anatomy 0.000 claims description 6
- 230000008529 pathological progression Effects 0.000 claims description 4
- 239000000427 antigen Substances 0.000 abstract description 46
- 108091007433 antigens Proteins 0.000 abstract description 46
- 102000036639 antigens Human genes 0.000 abstract description 46
- 239000000203 mixture Substances 0.000 abstract description 19
- 108090000623 proteins and genes Proteins 0.000 description 88
- 102000004169 proteins and genes Human genes 0.000 description 81
- 235000018102 proteins Nutrition 0.000 description 80
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 66
- 201000008628 secondary progressive multiple sclerosis Diseases 0.000 description 61
- 208000007118 chronic progressive multiple sclerosis Diseases 0.000 description 57
- 201000010099 disease Diseases 0.000 description 57
- 238000012360 testing method Methods 0.000 description 42
- 238000012549 training Methods 0.000 description 27
- 210000004027 cell Anatomy 0.000 description 26
- 108020004414 DNA Proteins 0.000 description 22
- 239000000463 material Substances 0.000 description 21
- 239000002299 complementary DNA Substances 0.000 description 20
- 238000011282 treatment Methods 0.000 description 20
- 102000039446 nucleic acids Human genes 0.000 description 19
- 108020004707 nucleic acids Proteins 0.000 description 19
- 150000007523 nucleic acids Chemical class 0.000 description 19
- 210000001519 tissue Anatomy 0.000 description 18
- 238000003491 array Methods 0.000 description 17
- 230000014509 gene expression Effects 0.000 description 14
- 208000024891 symptom Diseases 0.000 description 14
- 239000012491 analyte Substances 0.000 description 13
- 108020004999 messenger RNA Proteins 0.000 description 12
- 108090000765 processed proteins & peptides Proteins 0.000 description 12
- 238000007637 random forest analysis Methods 0.000 description 12
- 102000004196 processed proteins & peptides Human genes 0.000 description 10
- 102100037241 Endoglin Human genes 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 9
- 208000018737 Parkinson disease Diseases 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 230000007170 pathology Effects 0.000 description 9
- 238000003498 protein array Methods 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 8
- 239000011324 bead Substances 0.000 description 8
- 208000035475 disorder Diseases 0.000 description 8
- 230000035945 sensitivity Effects 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- 206010006187 Breast cancer Diseases 0.000 description 6
- 208000026310 Breast neoplasm Diseases 0.000 description 6
- 108010060616 DNA-3-methyladenine glycosidase II Proteins 0.000 description 6
- 102100039128 DNA-3-methyladenine glycosylase Human genes 0.000 description 6
- 102100023431 E3 ubiquitin-protein ligase TRIM21 Human genes 0.000 description 6
- 101000685877 Homo sapiens E3 ubiquitin-protein ligase TRIM21 Proteins 0.000 description 6
- 101000881679 Homo sapiens Endoglin Proteins 0.000 description 6
- 101000997314 Homo sapiens Voltage-gated potassium channel subunit beta-1 Proteins 0.000 description 6
- 102000053646 Inducible T-Cell Co-Stimulator Human genes 0.000 description 6
- 108700013161 Inducible T-Cell Co-Stimulator Proteins 0.000 description 6
- 102100026720 Interferon beta Human genes 0.000 description 6
- 108090000467 Interferon-beta Proteins 0.000 description 6
- 102100034081 Voltage-gated potassium channel subunit beta-1 Human genes 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 239000011230 binding agent Substances 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 238000012544 monitoring process Methods 0.000 description 6
- 229920001184 polypeptide Polymers 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 230000014616 translation Effects 0.000 description 6
- 238000013459 approach Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 230000028993 immune response Effects 0.000 description 5
- 238000002483 medication Methods 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000003127 radioimmunoassay Methods 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 102100020963 Actin-binding LIM protein 1 Human genes 0.000 description 4
- 101710123570 Actin-binding LIM protein 1 Proteins 0.000 description 4
- 102100029651 Arginine/serine-rich protein 1 Human genes 0.000 description 4
- 238000000018 DNA microarray Methods 0.000 description 4
- 102100039327 Enoyl-[acyl-carrier-protein] reductase, mitochondrial Human genes 0.000 description 4
- 102100037099 Homeobox protein MOX-1 Human genes 0.000 description 4
- 101710142879 Homeobox protein MOX-1 Proteins 0.000 description 4
- 101000728589 Homo sapiens Arginine/serine-rich protein 1 Proteins 0.000 description 4
- 101000961707 Homo sapiens Enoyl-[acyl-carrier-protein] reductase, mitochondrial Proteins 0.000 description 4
- 101001091610 Homo sapiens Krev interaction trapped protein 1 Proteins 0.000 description 4
- 101000752245 Homo sapiens Rho guanine nucleotide exchange factor 5 Proteins 0.000 description 4
- 101001123846 Homo sapiens Serine/threonine-protein kinase Nek1 Proteins 0.000 description 4
- 101000841477 Homo sapiens Ubiquitin carboxyl-terminal hydrolase 14 Proteins 0.000 description 4
- 101000997307 Homo sapiens Voltage-gated potassium channel subunit beta-2 Proteins 0.000 description 4
- 108090000144 Human Proteins Proteins 0.000 description 4
- 102000003839 Human Proteins Human genes 0.000 description 4
- 102100035878 Krev interaction trapped protein 1 Human genes 0.000 description 4
- 102100025904 MOB kinase activator 3C Human genes 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 4
- 102100021688 Rho guanine nucleotide exchange factor 5 Human genes 0.000 description 4
- 102100028751 Serine/threonine-protein kinase Nek1 Human genes 0.000 description 4
- 102100031913 Tumor protein D55 Human genes 0.000 description 4
- 101710190246 Tumor protein D55 Proteins 0.000 description 4
- 102100029163 Ubiquitin carboxyl-terminal hydrolase 14 Human genes 0.000 description 4
- 102100034074 Voltage-gated potassium channel subunit beta-2 Human genes 0.000 description 4
- 230000008499 blood brain barrier function Effects 0.000 description 4
- 210000001218 blood-brain barrier Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000011065 in-situ storage Methods 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 239000000816 peptidomimetic Substances 0.000 description 4
- -1 polymeric surfaces Substances 0.000 description 4
- 230000002285 radioactive effect Effects 0.000 description 4
- 102100025028 tRNA (guanine-N(7)-)-methyltransferase Human genes 0.000 description 4
- 101710112043 tRNA (guanine-N(7)-)-methyltransferase Proteins 0.000 description 4
- 230000007704 transition Effects 0.000 description 4
- 238000013519 translation Methods 0.000 description 4
- 108010047303 von Willebrand Factor Proteins 0.000 description 4
- 102100036537 von Willebrand factor Human genes 0.000 description 4
- 229960001134 von willebrand factor Drugs 0.000 description 4
- 108010059616 Activins Proteins 0.000 description 3
- 102000005606 Activins Human genes 0.000 description 3
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 3
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 3
- 102100027321 Beta-1,4-galactosyltransferase 7 Human genes 0.000 description 3
- 102100036956 Chromatin target of PRMT1 protein Human genes 0.000 description 3
- 206010061818 Disease progression Diseases 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- 108010036395 Endoglin Proteins 0.000 description 3
- 102100039835 Galactoside alpha-(1,2)-fucosyltransferase 1 Human genes 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 101000737958 Homo sapiens Chromatin target of PRMT1 protein Proteins 0.000 description 3
- 101001054334 Homo sapiens Interferon beta Proteins 0.000 description 3
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 3
- 102000003996 Interferon-beta Human genes 0.000 description 3
- 102000014150 Interferons Human genes 0.000 description 3
- 108010050904 Interferons Proteins 0.000 description 3
- 102100021754 LIM and senescent cell antigen-like-containing domain protein 1 Human genes 0.000 description 3
- 101710104356 LIM and senescent cell antigen-like-containing domain protein 1 Proteins 0.000 description 3
- 239000000488 activin Substances 0.000 description 3
- 230000004075 alteration Effects 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- 230000001363 autoimmune Effects 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 238000009534 blood test Methods 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000002059 diagnostic imaging Methods 0.000 description 3
- 230000005750 disease progression Effects 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 108020001507 fusion proteins Proteins 0.000 description 3
- 102000037865 fusion proteins Human genes 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000013632 homeostatic process Effects 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 229960001388 interferon-beta Drugs 0.000 description 3
- 238000011898 label-free detection Methods 0.000 description 3
- UBWXUGDQUBIEIZ-QNTYDACNSA-N nandrolone phenpropionate Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@H]4CCC(=O)C=C4CC3)CC[C@@]21C)C(=O)CCC1=CC=CC=C1 UBWXUGDQUBIEIZ-QNTYDACNSA-N 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 239000000123 paper Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 238000001308 synthesis method Methods 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 238000011269 treatment regimen Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 230000004572 zinc-binding Effects 0.000 description 3
- 102100039358 3-hydroxyacyl-CoA dehydrogenase type-2 Human genes 0.000 description 2
- 102100038684 5'-nucleotidase domain-containing protein 1 Human genes 0.000 description 2
- 102100029599 Advanced glycosylation end product-specific receptor Human genes 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 102100021954 Alpha-tubulin N-acetyltransferase 1 Human genes 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- 102100035765 Angiotensin-converting enzyme 2 Human genes 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 2
- 102100032307 BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 Human genes 0.000 description 2
- 102100025423 Bone morphogenetic protein receptor type-1A Human genes 0.000 description 2
- 101710113502 Branchpoint-bridging protein Proteins 0.000 description 2
- 101710113561 Breast cancer metastasis-suppressor 1 Proteins 0.000 description 2
- 102100024791 Breast cancer metastasis-suppressor 1-like protein Human genes 0.000 description 2
- 102100027207 CD27 antigen Human genes 0.000 description 2
- 102100038817 CDGSH iron-sulfur domain-containing protein 1 Human genes 0.000 description 2
- 102100029391 Cardiotrophin-like cytokine factor 1 Human genes 0.000 description 2
- 101710107109 Cardiotrophin-like cytokine factor 1 Proteins 0.000 description 2
- 108010078791 Carrier Proteins Proteins 0.000 description 2
- 102100039550 Chemokine-like factor Human genes 0.000 description 2
- 101710204213 Chemokine-like factor Proteins 0.000 description 2
- 102100030871 Cleavage and polyadenylation specificity factor subunit 5 Human genes 0.000 description 2
- 102100030781 Collagen alpha-1(XXIII) chain Human genes 0.000 description 2
- 102000005228 Cyclic AMP Response Element Modulator Human genes 0.000 description 2
- 108010056281 Cyclic AMP Response Element Modulator Proteins 0.000 description 2
- 108010024986 Cyclin-Dependent Kinase 2 Proteins 0.000 description 2
- 102100036239 Cyclin-dependent kinase 2 Human genes 0.000 description 2
- 102100031051 Cysteine and glycine-rich protein 1 Human genes 0.000 description 2
- 101710185487 Cysteine and glycine-rich protein 1 Proteins 0.000 description 2
- 102100029411 Cytochrome c oxidase assembly factor 8 Human genes 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 102100037377 DNA-(apurinic or apyrimidinic site) endonuclease 2 Human genes 0.000 description 2
- 102100038631 E3 ubiquitin-protein ligase SMURF1 Human genes 0.000 description 2
- 102100034235 ELAV-like protein 1 Human genes 0.000 description 2
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 2
- 102100035290 Fibroblast growth factor 13 Human genes 0.000 description 2
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
- 102100027909 Folliculin Human genes 0.000 description 2
- 101710182803 Folliculin Proteins 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 102100025413 Formyltetrahydrofolate synthetase Human genes 0.000 description 2
- 102100030393 G-patch domain and KOW motifs-containing protein Human genes 0.000 description 2
- 102100038073 General transcription factor II-I Human genes 0.000 description 2
- 101710144827 General transcription factor II-I Proteins 0.000 description 2
- 102100039275 Glycine N-acyltransferase-like protein 2 Human genes 0.000 description 2
- 102100031493 Growth arrest-specific protein 7 Human genes 0.000 description 2
- 102100029240 Homeobox protein Hox-B5 Human genes 0.000 description 2
- 102100034826 Homeobox protein Meis2 Human genes 0.000 description 2
- 101001035740 Homo sapiens 3-hydroxyacyl-CoA dehydrogenase type-2 Proteins 0.000 description 2
- 101000604528 Homo sapiens 5'-nucleotidase domain-containing protein 1 Proteins 0.000 description 2
- 101000753184 Homo sapiens Alpha-tubulin N-acetyltransferase 1 Proteins 0.000 description 2
- 101000798319 Homo sapiens BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 Proteins 0.000 description 2
- 101000934638 Homo sapiens Bone morphogenetic protein receptor type-1A Proteins 0.000 description 2
- 101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 2
- 101000883055 Homo sapiens CDGSH iron-sulfur domain-containing protein 1 Proteins 0.000 description 2
- 101000727072 Homo sapiens Cleavage and polyadenylation specificity factor subunit 5 Proteins 0.000 description 2
- 101000920176 Homo sapiens Collagen alpha-1(XXIII) chain Proteins 0.000 description 2
- 101000771332 Homo sapiens Cytochrome c oxidase assembly factor 8 Proteins 0.000 description 2
- 101000806823 Homo sapiens DNA-(apurinic or apyrimidinic site) endonuclease 2 Proteins 0.000 description 2
- 101001009694 Homo sapiens G-patch domain and KOW motifs-containing protein Proteins 0.000 description 2
- 101000888229 Homo sapiens Glycine N-acyltransferase-like protein 2 Proteins 0.000 description 2
- 101000923044 Homo sapiens Growth arrest-specific protein 7 Proteins 0.000 description 2
- 101000840553 Homo sapiens Homeobox protein Hox-B5 Proteins 0.000 description 2
- 101001019057 Homo sapiens Homeobox protein Meis2 Proteins 0.000 description 2
- 101000840582 Homo sapiens Insulin-like growth factor-binding protein 6 Proteins 0.000 description 2
- 101000599048 Homo sapiens Interleukin-6 receptor subunit alpha Proteins 0.000 description 2
- 101000576163 Homo sapiens MOB kinase activator 3C Proteins 0.000 description 2
- 101000985328 Homo sapiens Methenyltetrahydrofolate cyclohydrolase Proteins 0.000 description 2
- 101001132841 Homo sapiens Mitochondrial ribosome-associated GTPase 1 Proteins 0.000 description 2
- 101000721717 Homo sapiens NTF2-related export protein 2 Proteins 0.000 description 2
- 101000586232 Homo sapiens ORM1-like protein 3 Proteins 0.000 description 2
- 101000693236 Homo sapiens PDZ domain-containing protein 7 Proteins 0.000 description 2
- 101000692247 Homo sapiens Phagosome assembly factor 1 Proteins 0.000 description 2
- 101000611936 Homo sapiens Programmed cell death protein 1 Proteins 0.000 description 2
- 101000733266 Homo sapiens Rho guanine nucleotide exchange factor 35 Proteins 0.000 description 2
- 101000712821 Homo sapiens Ribosomal biogenesis factor Proteins 0.000 description 2
- 101000609920 Homo sapiens Sister chromatid cohesion protein PDS5 homolog A Proteins 0.000 description 2
- 101000824992 Homo sapiens Spermatogenesis-associated serine-rich protein 2 Proteins 0.000 description 2
- 101000610604 Homo sapiens Tumor necrosis factor receptor superfamily member 10B Proteins 0.000 description 2
- 101000617779 Homo sapiens U1 small nuclear ribonucleoprotein A Proteins 0.000 description 2
- 102100029180 Insulin-like growth factor-binding protein 6 Human genes 0.000 description 2
- 102100039734 Interferon alpha-10 Human genes 0.000 description 2
- 102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 description 2
- 102100026023 LIM domain kinase 1 Human genes 0.000 description 2
- 101710107718 LIM domain kinase 1 Proteins 0.000 description 2
- 108010010685 Methenyltetrahydrofolate cyclohydrolase Proteins 0.000 description 2
- 102100028687 Methenyltetrahydrofolate cyclohydrolase Human genes 0.000 description 2
- 108010058682 Mitochondrial Proteins Proteins 0.000 description 2
- 102000006404 Mitochondrial Proteins Human genes 0.000 description 2
- 102100033815 Mitochondrial ribosome-associated GTPase 1 Human genes 0.000 description 2
- 102100034256 Mucin-1 Human genes 0.000 description 2
- 108010008707 Mucin-1 Proteins 0.000 description 2
- 102000006386 Myelin Proteins Human genes 0.000 description 2
- 108010083674 Myelin Proteins Proteins 0.000 description 2
- 102100025112 NTF2-related export protein 2 Human genes 0.000 description 2
- 208000012902 Nervous system disease Diseases 0.000 description 2
- 208000025966 Neurological disease Diseases 0.000 description 2
- 108090000772 Neuropilin-1 Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 102100030120 ORM1-like protein 3 Human genes 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 102100026171 P2Y purinoceptor 12 Human genes 0.000 description 2
- 102100040915 PABIR family member 1 Human genes 0.000 description 2
- 102100025651 PDZ domain-containing protein 7 Human genes 0.000 description 2
- 102000007079 Peptide Fragments Human genes 0.000 description 2
- 108010033276 Peptide Fragments Proteins 0.000 description 2
- 108010043958 Peptoids Proteins 0.000 description 2
- 102100026062 Phagosome assembly factor 1 Human genes 0.000 description 2
- 102100036163 Phosphatidylinositol N-acetylglucosaminyltransferase subunit C Human genes 0.000 description 2
- 101710109732 Phosphatidylinositol N-acetylglucosaminyltransferase subunit C Proteins 0.000 description 2
- 102100033237 Pro-epidermal growth factor Human genes 0.000 description 2
- 102100040678 Programmed cell death protein 1 Human genes 0.000 description 2
- 108010029485 Protein Isoforms Proteins 0.000 description 2
- 102000001708 Protein Isoforms Human genes 0.000 description 2
- 108010014270 Purinergic P2Y12 Receptors Proteins 0.000 description 2
- 102100034835 Putative killer cell immunoglobulin-like receptor-like protein KIR3DX1 Human genes 0.000 description 2
- 101710098053 Putative killer cell immunoglobulin-like receptor-like protein KIR3DX1 Proteins 0.000 description 2
- 108010045108 Receptor for Advanced Glycation End Products Proteins 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 102100033169 Ribosomal biogenesis factor Human genes 0.000 description 2
- 102100039166 Sister chromatid cohesion protein PDS5 homolog A Human genes 0.000 description 2
- 102000004598 Small Nuclear Ribonucleoproteins Human genes 0.000 description 2
- 108010003165 Small Nuclear Ribonucleoproteins Proteins 0.000 description 2
- 102100022445 Spermatogenesis-associated serine-rich protein 2 Human genes 0.000 description 2
- 101710153291 Splicing factor 1 Proteins 0.000 description 2
- 102100030056 Splicing factor 1 Human genes 0.000 description 2
- 102100030951 Tissue factor pathway inhibitor Human genes 0.000 description 2
- 102100022610 Trafficking protein particle complex subunit 2-like protein Human genes 0.000 description 2
- 101710087408 Trafficking protein particle complex subunit 2-like protein Proteins 0.000 description 2
- 101710081312 Trans-2-enoyl-CoA reductase Proteins 0.000 description 2
- 102100033331 Transcription factor AP-2-delta Human genes 0.000 description 2
- 102100040112 Tumor necrosis factor receptor superfamily member 10B Human genes 0.000 description 2
- 102100022013 U1 small nuclear ribonucleoprotein A Human genes 0.000 description 2
- 206010072731 White matter lesion Diseases 0.000 description 2
- 102100035849 Zinc finger protein 462 Human genes 0.000 description 2
- 101710143632 Zinc finger protein 462 Proteins 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000003466 anti-cipated effect Effects 0.000 description 2
- 210000003050 axon Anatomy 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000008029 eradication Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000005713 exacerbation Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 108010079306 galactoside 2-alpha-L-fucosyltransferase Proteins 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000007641 inkjet printing Methods 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 238000009593 lumbar puncture Methods 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000002438 mitochondrial effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000003007 myelin sheath Anatomy 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 208000015122 neurodegenerative disease Diseases 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 239000013610 patient sample Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 229920000642 polymer Chemical group 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 210000001995 reticulocyte Anatomy 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 210000004885 white matter Anatomy 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 108091064702 1 family Proteins 0.000 description 1
- KISWVXRQTGLFGD-UHFFFAOYSA-N 2-[[2-[[6-amino-2-[[2-[[2-[[5-amino-2-[[2-[[1-[2-[[6-amino-2-[(2,5-diamino-5-oxopentanoyl)amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-(diaminomethylideneamino)p Chemical compound C1CCN(C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(N)CCC(N)=O)C1C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 KISWVXRQTGLFGD-UHFFFAOYSA-N 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- 102100021176 ATP-sensitive inward rectifier potassium channel 10 Human genes 0.000 description 1
- 239000012114 Alexa Fluor 647 Substances 0.000 description 1
- 239000012099 Alexa Fluor family Substances 0.000 description 1
- 102000003730 Alpha-catenin Human genes 0.000 description 1
- 108090000020 Alpha-catenin Proteins 0.000 description 1
- 101710205883 Amino-terminal enhancer of split Proteins 0.000 description 1
- 241001465677 Ancylostomatoidea Species 0.000 description 1
- 108090000975 Angiotensin-converting enzyme 2 Proteins 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 102100026291 Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 Human genes 0.000 description 1
- 101710112065 Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 Proteins 0.000 description 1
- 241000351920 Aspergillus nidulans Species 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102100027522 Baculoviral IAP repeat-containing protein 7 Human genes 0.000 description 1
- 101710177963 Baculoviral IAP repeat-containing protein 7 Proteins 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 102100023995 Beta-nerve growth factor Human genes 0.000 description 1
- 101710129634 Beta-nerve growth factor Proteins 0.000 description 1
- 206010069632 Bladder dysfunction Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 101000741742 Bos taurus Serine protease 45 Proteins 0.000 description 1
- 102100021714 Bystin Human genes 0.000 description 1
- 101710128052 Bystin Proteins 0.000 description 1
- 102100025279 C-X-C motif chemokine 11 Human genes 0.000 description 1
- 101710098272 C-X-C motif chemokine 11 Proteins 0.000 description 1
- 102000049320 CD36 Human genes 0.000 description 1
- 108010045374 CD36 Antigens Proteins 0.000 description 1
- 102100040530 CKLF-like MARVEL transmembrane domain-containing protein 1 Human genes 0.000 description 1
- 101710165701 CKLF-like MARVEL transmembrane domain-containing protein 1 Proteins 0.000 description 1
- 102100035768 Calcyphosin-like protein Human genes 0.000 description 1
- 101710190056 Calcyphosin-like protein Proteins 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 206010071068 Clinically isolated syndrome Diseases 0.000 description 1
- 108020005199 Dehydrogenases Proteins 0.000 description 1
- 102100033553 Delta-like protein 4 Human genes 0.000 description 1
- 208000016192 Demyelinating disease Diseases 0.000 description 1
- 206010012305 Demyelination Diseases 0.000 description 1
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- BVTJGGGYKAMDBN-UHFFFAOYSA-N Dioxetane Chemical class C1COO1 BVTJGGGYKAMDBN-UHFFFAOYSA-N 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- 101710109086 E3 ubiquitin-protein ligase SMURF1 Proteins 0.000 description 1
- 108700015856 ELAV-Like Protein 1 Proteins 0.000 description 1
- 101150011861 Elavl1 gene Proteins 0.000 description 1
- 108010003751 Elongin Proteins 0.000 description 1
- 102000004662 Elongin Human genes 0.000 description 1
- 102100030209 Elongin-B Human genes 0.000 description 1
- 102100023721 Ephrin-B2 Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 208000014540 Functional gastrointestinal disease Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102100023734 G protein-coupled receptor kinase 4 Human genes 0.000 description 1
- 108010056706 G-Protein-Coupled Receptor Kinase 4 Proteins 0.000 description 1
- 108010072051 Glatiramer Acetate Proteins 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 102100036738 Guanine nucleotide-binding protein subunit alpha-11 Human genes 0.000 description 1
- 101710137155 Guanine nucleotide-binding protein subunit alpha-11 Proteins 0.000 description 1
- 108010093488 His-His-His-His-His-His Proteins 0.000 description 1
- 102100039265 Histone H2A type 1-C Human genes 0.000 description 1
- 101710132515 Histone H2A type 1-C Proteins 0.000 description 1
- 102100022103 Histone-lysine N-methyltransferase 2A Human genes 0.000 description 1
- 102300051372 Homeodomain-interacting protein kinase 3 isoform 1 Human genes 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000929928 Homo sapiens Angiotensin-converting enzyme 2 Proteins 0.000 description 1
- 101000937508 Homo sapiens Beta-1,4-galactosyltransferase 7 Proteins 0.000 description 1
- 101000872077 Homo sapiens Delta-like protein 4 Proteins 0.000 description 1
- 101000664993 Homo sapiens E3 ubiquitin-protein ligase SMURF1 Proteins 0.000 description 1
- 101000925870 Homo sapiens ELAV-like protein 1 Proteins 0.000 description 1
- 101001011846 Homo sapiens Elongin-B Proteins 0.000 description 1
- 101001049392 Homo sapiens Ephrin-B2 Proteins 0.000 description 1
- 101000885616 Homo sapiens Galactoside alpha-(1,2)-fucosyltransferase 1 Proteins 0.000 description 1
- 101001045846 Homo sapiens Histone-lysine N-methyltransferase 2A Proteins 0.000 description 1
- 101600085189 Homo sapiens Homeodomain-interacting protein kinase 3 (isoform 1) Proteins 0.000 description 1
- 101001034829 Homo sapiens Interferon alpha-10 Proteins 0.000 description 1
- 101001076418 Homo sapiens Interleukin-1 receptor type 1 Proteins 0.000 description 1
- 101000777658 Homo sapiens Platelet glycoprotein 4 Proteins 0.000 description 1
- 101000892360 Homo sapiens Protein AF-17 Proteins 0.000 description 1
- 101000897999 Homo sapiens Protein Hikeshi Proteins 0.000 description 1
- 101000741739 Homo sapiens Putative serine protease 45 Proteins 0.000 description 1
- 101000653189 Homo sapiens Tissue factor pathway inhibitor Proteins 0.000 description 1
- 101000732353 Homo sapiens Transcription factor AP-2-delta Proteins 0.000 description 1
- 101000837565 Homo sapiens Ubiquitin-conjugating enzyme E2 S Proteins 0.000 description 1
- 108010058683 Immobilized Proteins Proteins 0.000 description 1
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 101710106873 Interferon alpha-10 Proteins 0.000 description 1
- 108010005716 Interferon beta-1a Proteins 0.000 description 1
- 102100026016 Interleukin-1 receptor type 1 Human genes 0.000 description 1
- 101710144279 Intraflagellar transport protein 81 homolog Proteins 0.000 description 1
- 102100030001 Intraflagellar transport protein 81 homolog Human genes 0.000 description 1
- 108090000862 Ion Channels Proteins 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- 108010074781 Kcnj10 (channel) Proteins 0.000 description 1
- 102000004034 Kelch-Like ECH-Associated Protein 1 Human genes 0.000 description 1
- 108090000484 Kelch-Like ECH-Associated Protein 1 Proteins 0.000 description 1
- 108091077621 MAPRE family Proteins 0.000 description 1
- 102000042257 MAPRE family Human genes 0.000 description 1
- 102000014385 Mediator of RNA polymerase II transcription subunit 22 Human genes 0.000 description 1
- 108050003409 Mediator of RNA polymerase II transcription subunit 22 Proteins 0.000 description 1
- FQISKWAFAHGMGT-SGJOWKDISA-M Methylprednisolone sodium succinate Chemical compound [Na+].C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)COC(=O)CCC([O-])=O)CC[C@H]21 FQISKWAFAHGMGT-SGJOWKDISA-M 0.000 description 1
- 108010020004 Microtubule-Associated Proteins Proteins 0.000 description 1
- 102000009664 Microtubule-Associated Proteins Human genes 0.000 description 1
- 102100024193 Mitogen-activated protein kinase 1 Human genes 0.000 description 1
- 108700015928 Mitogen-activated protein kinase 13 Proteins 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 102000047918 Myelin Basic Human genes 0.000 description 1
- 102000055324 Myelin Proteolipid Human genes 0.000 description 1
- 101710107068 Myelin basic protein Proteins 0.000 description 1
- 101710094913 Myelin proteolipid protein Proteins 0.000 description 1
- 102000017099 Myelin-Associated Glycoprotein Human genes 0.000 description 1
- 108010013731 Myelin-Associated Glycoprotein Proteins 0.000 description 1
- 102000002233 Myelin-Oligodendrocyte Glycoprotein Human genes 0.000 description 1
- 108010000123 Myelin-Oligodendrocyte Glycoprotein Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102100028762 Neuropilin-1 Human genes 0.000 description 1
- 102000004207 Neuropilin-1 Human genes 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 102100035689 Outer dense fiber protein 3-like protein 2 Human genes 0.000 description 1
- 101710160046 Outer dense fiber protein 3-like protein 2 Proteins 0.000 description 1
- 101710168475 PABIR family member 1 Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 102000002508 Peptide Elongation Factors Human genes 0.000 description 1
- 108010068204 Peptide Elongation Factors Proteins 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 102100031574 Platelet glycoprotein 4 Human genes 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 102100040638 Protein AF-17 Human genes 0.000 description 1
- 102100021863 Protein Hikeshi Human genes 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 102100038786 Putative serine protease 45 Human genes 0.000 description 1
- 101710134436 Putative uncharacterized protein Proteins 0.000 description 1
- 230000026279 RNA modification Effects 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 102100029942 Small cell adhesion glycoprotein Human genes 0.000 description 1
- 101710170111 Small cell adhesion glycoprotein Proteins 0.000 description 1
- 102100034803 Small nuclear ribonucleoprotein-associated protein N Human genes 0.000 description 1
- 102100021996 Staphylococcal nuclease domain-containing protein 1 Human genes 0.000 description 1
- 101710171257 Staphylococcal nuclease domain-containing protein 1 Proteins 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 101710187338 TLE family member 5 Proteins 0.000 description 1
- 102100033766 TLE family member 5 Human genes 0.000 description 1
- 102100034999 Thymosin beta-4, Y-chromosomal Human genes 0.000 description 1
- 101710177519 Thymosin beta-4, Y-chromosomal Proteins 0.000 description 1
- 102100027645 Tigger transposable element-derived protein 1 Human genes 0.000 description 1
- 101710169255 Tigger transposable element-derived protein 1 Proteins 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108090001039 Transcription factor AP-2 Proteins 0.000 description 1
- 102000004893 Transcription factor AP-2 Human genes 0.000 description 1
- 101710113004 Transcription factor AP-2-delta Proteins 0.000 description 1
- 108010066451 Triggering Receptor Expressed on Myeloid Cells-1 Proteins 0.000 description 1
- 102000018368 Triggering Receptor Expressed on Myeloid Cells-1 Human genes 0.000 description 1
- 102100028718 Ubiquitin-conjugating enzyme E2 S Human genes 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 108090000013 Voltage-Gated Potassium Channels Proteins 0.000 description 1
- 102000003734 Voltage-Gated Potassium Channels Human genes 0.000 description 1
- 101100445056 Xenopus laevis elavl1-a gene Proteins 0.000 description 1
- 101100445057 Xenopus laevis elavl1-b gene Proteins 0.000 description 1
- 108010063641 Xylosylprotein 4-beta-galactosyltransferase Proteins 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- FHEAIOHRHQGZPC-KIWGSFCNSA-N acetic acid;(2s)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2s)-2-aminopentanedioic acid;(2s)-2-aminopropanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound CC(O)=O.C[C@H](N)C(O)=O.NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CCC(O)=O.OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 FHEAIOHRHQGZPC-KIWGSFCNSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229960000548 alemtuzumab Drugs 0.000 description 1
- 230000001668 ameliorated effect Effects 0.000 description 1
- 230000006933 amyloid-beta aggregation Effects 0.000 description 1
- 230000003941 amyloidogenesis Effects 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 238000002820 assay format Methods 0.000 description 1
- 230000003376 axonal effect Effects 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 230000008436 biogenesis Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000000091 biomarker candidate Substances 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 201000007637 bowel dysfunction Diseases 0.000 description 1
- 210000004780 brain interstitium Anatomy 0.000 description 1
- 238000004422 calculation algorithm Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000002041 carbon nanotube Substances 0.000 description 1
- 229910021393 carbon nanotube Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000009087 cell motility Effects 0.000 description 1
- 210000004671 cell-free system Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000009614 chemical analysis method Methods 0.000 description 1
- 238000012412 chemical coupling Methods 0.000 description 1
- 239000012707 chemical precursor Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000006999 cognitive decline Effects 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000002508 contact lithography Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 238000013211 curve analysis Methods 0.000 description 1
- 238000003066 decision tree Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000021004 dietary regimen Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
- LDCRTTXIJACKKU-ONEGZZNKSA-N dimethyl fumarate Chemical compound COC(=O)\C=C\C(=O)OC LDCRTTXIJACKKU-ONEGZZNKSA-N 0.000 description 1
- 229960004419 dimethyl fumarate Drugs 0.000 description 1
- 230000009266 disease activity Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003596 drug target Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229960000556 fingolimod Drugs 0.000 description 1
- KKGQTZUTZRNORY-UHFFFAOYSA-N fingolimod Chemical compound CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1 KKGQTZUTZRNORY-UHFFFAOYSA-N 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 229960003776 glatiramer acetate Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 210000004884 grey matter Anatomy 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 238000002639 hyperbaric oxygen therapy Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 229940027941 immunoglobulin g Drugs 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000036540 impulse transmission Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 238000005305 interferometry Methods 0.000 description 1
- 229960004461 interferon beta-1a Drugs 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 229940124625 intravenous corticosteroids Drugs 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 108010013555 lipoprotein-associated coagulation inhibitor Proteins 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000003712 lysosome Anatomy 0.000 description 1
- 230000001868 lysosomic effect Effects 0.000 description 1
- 238000010801 machine learning Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 240000004308 marijuana Species 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229960004584 methylprednisolone Drugs 0.000 description 1
- 238000010208 microarray analysis Methods 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 229960001156 mitoxantrone Drugs 0.000 description 1
- KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 description 1
- 241000514897 mixed subtypes Species 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000005012 myelin Anatomy 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 239000002070 nanowire Substances 0.000 description 1
- 229960005027 natalizumab Drugs 0.000 description 1
- 238000013188 needle biopsy Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 210000004498 neuroglial cell Anatomy 0.000 description 1
- 230000002314 neuroinflammatory effect Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 230000004031 neuronal differentiation Effects 0.000 description 1
- 230000008062 neuronal firing Effects 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229950005751 ocrelizumab Drugs 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 210000001328 optic nerve Anatomy 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 210000004910 pleural fluid Anatomy 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 229960004641 rituximab Drugs 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 238000013390 scatchard method Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 108010039827 snRNP Core Proteins Proteins 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000007847 structural defect Effects 0.000 description 1
- 230000002739 subcortical effect Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- UTNUDOFZCWSZMS-YFHOEESVSA-N teriflunomide Chemical compound C\C(O)=C(/C#N)C(=O)NC1=CC=C(C(F)(F)F)C=C1 UTNUDOFZCWSZMS-YFHOEESVSA-N 0.000 description 1
- 229960000331 teriflunomide Drugs 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000005029 transcription elongation Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
- G01N33/552—Glass or silica
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/285—Demyelinating diseases; Multipel sclerosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Inorganic Chemistry (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762504130P | 2017-05-10 | 2017-05-10 | |
| US62/504,130 | 2017-05-10 | ||
| PCT/US2018/032130 WO2018209126A1 (en) | 2017-05-10 | 2018-05-10 | Diagnostic biomarkers for detecting, subtyping, and/or assessing progression of multiple sclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3062763A1 true CA3062763A1 (en) | 2018-11-15 |
Family
ID=64104996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3062763A Pending CA3062763A1 (en) | 2017-05-10 | 2018-05-10 | Diagnostic biomarkers for detecting, subtyping, and/or assessing progression of multiple sclerosis |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US20210003570A1 (enExample) |
| EP (1) | EP3622291A4 (enExample) |
| JP (1) | JP7146286B2 (enExample) |
| CA (1) | CA3062763A1 (enExample) |
| WO (1) | WO2018209126A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116113701A (zh) * | 2020-08-03 | 2023-05-12 | 普利维尔治疗公司 | 编码parkin的aav载体及其用途 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110186962B (zh) * | 2019-05-10 | 2021-06-25 | 天津大学 | 一种用于电容层析成像的不完整测量数据成像方法 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| US5856092A (en) | 1989-02-13 | 1999-01-05 | Geneco Pty Ltd | Detection of a nucleic acid sequence or a change therein |
| US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| US5547839A (en) | 1989-06-07 | 1996-08-20 | Affymax Technologies N.V. | Sequencing of surface immobilized polymers utilizing microflourescence detection |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US5424186A (en) | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
| JP2001524926A (ja) | 1991-09-18 | 2001-12-04 | アフィマックス テクノロジーズ ナームロゼ フェンノートシャップ | オリゴマーの雑多ライブラリーの集合体を合成する方法 |
| US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
| ATE262374T1 (de) | 1991-11-22 | 2004-04-15 | Affymetrix Inc | Kombinatorische strategien für polymersynthese |
| US5837832A (en) | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
| US6027880A (en) | 1995-08-02 | 2000-02-22 | Affymetrix, Inc. | Arrays of nucleic acid probes and methods of using the same for detecting cystic fibrosis |
| US5861242A (en) | 1993-06-25 | 1999-01-19 | Affymetrix, Inc. | Array of nucleic acid probes on biological chips for diagnosis of HIV and methods of using the same |
| US6090555A (en) | 1997-12-11 | 2000-07-18 | Affymetrix, Inc. | Scanned image alignment systems and methods |
| US5631734A (en) | 1994-02-10 | 1997-05-20 | Affymetrix, Inc. | Method and apparatus for detection of fluorescently labeled materials |
| US5578832A (en) | 1994-09-02 | 1996-11-26 | Affymetrix, Inc. | Method and apparatus for imaging a sample on a device |
| US5856174A (en) | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
| EP0902885A4 (en) | 1996-05-16 | 2006-09-27 | Affymetrix Inc | SYSTEMS AND METHODS FOR DETECTION OF BRANDED PRODUCTS |
| ATE296898T1 (de) | 1997-03-20 | 2005-06-15 | Affymetrix Inc | Iterative resequenzierung |
| US6201639B1 (en) | 1998-03-20 | 2001-03-13 | James W. Overbeck | Wide field of view and high speed scanning microscopy |
| US6185030B1 (en) | 1998-03-20 | 2001-02-06 | James W. Overbeck | Wide field of view and high speed scanning microscopy |
| US5936324A (en) | 1998-03-30 | 1999-08-10 | Genetic Microsystems Inc. | Moving magnet scanner |
| US6218803B1 (en) | 1999-06-04 | 2001-04-17 | Genetic Microsystems, Inc. | Position sensing with variable capacitance transducers |
| DE60332406D1 (de) | 2002-03-15 | 2010-06-17 | Affymetrix Inc | System und Verfahren zur Abtastung von biologischen Materialien |
| US20050032074A1 (en) | 2002-09-09 | 2005-02-10 | Affymetrix, Inc. | Custom design method for resequencing arrays |
| US7300788B2 (en) | 2002-10-08 | 2007-11-27 | Affymetrix, Inc. | Method for genotyping polymorphisms in humans |
| CN1735808A (zh) | 2002-11-07 | 2006-02-15 | 鹿特丹伊拉兹马斯大学 | 用于检测相互作用的分子的fret探针和方法 |
| US7317415B2 (en) | 2003-08-08 | 2008-01-08 | Affymetrix, Inc. | System, method, and product for scanning of biological materials employing dual analog integrators |
| WO2011142901A1 (en) * | 2010-05-13 | 2011-11-17 | University Of Medicine And Dentistry Of New Jersey | Diagnostic biomarker profiles for the detection and diagnosis of alzheimer's disease |
| US10132817B2 (en) | 2011-07-12 | 2018-11-20 | Rowan University | Diagnostic biomarker profiles for the detection and diagnosis of alzheimer's disease |
| US9746482B2 (en) | 2011-08-11 | 2017-08-29 | Rowan University | Diagnostic biomarker profiles for the detection and diagnosis of parkinsons disease |
-
2018
- 2018-05-10 US US16/611,951 patent/US20210003570A1/en not_active Abandoned
- 2018-05-10 JP JP2019562415A patent/JP7146286B2/ja active Active
- 2018-05-10 EP EP18798139.4A patent/EP3622291A4/en not_active Withdrawn
- 2018-05-10 CA CA3062763A patent/CA3062763A1/en active Pending
- 2018-05-10 WO PCT/US2018/032130 patent/WO2018209126A1/en not_active Ceased
-
2022
- 2022-08-18 US US17/820,815 patent/US20220390448A1/en active Pending
- 2022-08-18 US US17/820,803 patent/US12174187B2/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116113701A (zh) * | 2020-08-03 | 2023-05-12 | 普利维尔治疗公司 | 编码parkin的aav载体及其用途 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3622291A4 (en) | 2021-04-21 |
| EP3622291A1 (en) | 2020-03-18 |
| JP7146286B2 (ja) | 2022-10-04 |
| JP2020519895A (ja) | 2020-07-02 |
| US12174187B2 (en) | 2024-12-24 |
| US20220390447A1 (en) | 2022-12-08 |
| US20220390448A1 (en) | 2022-12-08 |
| WO2018209126A1 (en) | 2018-11-15 |
| US20210003570A1 (en) | 2021-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2965090B1 (en) | Methods and compositions for the diagnosis of alzheimer's disease | |
| US20120178637A1 (en) | Biomarkers and methods for detecting alzheimer's disease | |
| US20160041165A1 (en) | A blood biomarker that predicts persistent cognitive dysfunction after concussion | |
| US9746482B2 (en) | Diagnostic biomarker profiles for the detection and diagnosis of parkinsons disease | |
| US11187708B2 (en) | Early stage Parkinson's disease diagnostic kits and methods | |
| US12174187B2 (en) | Methods for detecting multiple sclerosis (MS) diagnostic autoantibodies | |
| CN113075414A (zh) | 用于诊断眼表炎症和干眼病的方法和装置 | |
| US20150293120A1 (en) | Marker sequences for rheumatoid arthritis | |
| US20100261881A1 (en) | Marker sequences for rheumatoid arthritis and use thereof | |
| US11619632B2 (en) | Early-stage Alzheimer's disease autoantibody biomarkers, target antigens and diagnostic uses thereof | |
| JP5924502B2 (ja) | リンパ球性漏斗下垂体後葉炎のバイオマーカー及びその用途 | |
| AU2021203920A1 (en) | Biomarkers for detection of breast cancer | |
| EP3545311A1 (en) | Gfap derivatives for stroke diagnostics | |
| EP2735875A1 (en) | Marker sequences for Neuromyelitis Optica (NMO) and use thereof | |
| WO2017168014A1 (de) | Markersequenzen für rheumatoide arthritis | |
| CN115209917A (zh) | 用于检测花生过敏的测定法 | |
| US20250306021A1 (en) | Sero-Reactive Antigens for Coccidioidomycosis | |
| AU2008295291A1 (en) | Marker sequences for multiple sclerosis and use thereof | |
| HK40045405A (en) | Methods and devices for diagnosing ocular surface inflammation and dry eye disease | |
| HK1144015A (en) | Marker sequences for rheumatoid arthritis and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220914 |
|
| EEER | Examination request |
Effective date: 20220914 |
|
| EEER | Examination request |
Effective date: 20220914 |
|
| EEER | Examination request |
Effective date: 20220914 |
|
| EEER | Examination request |
Effective date: 20220914 |